Table of Contents Author Guidelines Submit a Manuscript
International Journal of Biomedical Imaging
Volume 2013 (2013), Article ID 576470, 9 pages
http://dx.doi.org/10.1155/2013/576470
Research Article

Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging Data to Constrain a Positron Emission Tomography Kinetic Model: Theory and Simulations

1Department of Radiology, Northwestern University, Chicago, IL 60611, USA
2Institute of Imaging Science, Vanderbilt University, Nashville, TN 37212, USA
3Department of Radiology and Radiological Sciences, Vanderbilt University, Nashville, TN 37212, USA
4Program in Chemical and Physical Biology, Vanderbilt University, Nashville, TN 37212, USA
5Department of Physics and Astronomy, Vanderbilt University, Nashville, TN 37212, USA
6Department of Biomedical Engineering, Vanderbilt University, Nashville, TN 37212, USA
7Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN 37212, USA
8Department of Cancer Biology, Vanderbilt University, Nashville, TN 37212, USA

Received 8 April 2013; Accepted 29 August 2013

Academic Editor: Guowei Wei

Copyright © 2013 Jacob U. Fluckiger et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Ikoma, H. Watabe, M. Shidahara, M. Naganawa, and Y. Kimura, “PET kinetic analysis: error consideration of quantitative analysis in dynamic studies,” Annals of Nuclear Medicine, vol. 22, no. 1, pp. 1–11, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. K. C. Schmidt and F. E. Turkheimer, “Kinetic modeling in positron emission tomography,” Quarterly Journal of Nuclear Medicine, vol. 46, no. 1, pp. 70–85, 2002. View at Google Scholar · View at Scopus
  3. T. E. Yankeelov and J. C. Gore, “Dynamic contrast enhanced magnetic resonance imaging in oncology: theory, data acquisition, analysis, and examples,” Current Medical Imaging Reviews, vol. 3, no. 2, pp. 91–107, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. I. Asllani, A. Borogovac, and T. R. Brown, “Regression algorithm correcting for partial volume effects in arterial spin labeling MRI,” Magnetic Resonance in Medicine, vol. 60, no. 6, pp. 1362–1371, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Muzi, D. A. Mankoff, J. R. Grierson, J. M. Wells, H. Vesselle, and K. A. Krohn, “Kinetic modeling of 3′-deoxy-3′-fluorothymidine in somatic tumors: mathematical studies,” Journal of Nuclear Medicine, vol. 46, no. 2, pp. 371–380, 2005. View at Google Scholar · View at Scopus
  6. M. Muzi, A. M. Spence, F. O'Sullivan et al., “Kinetic analysis of 3′-deoxy-3′-18F-fluorothymidine in patients with gliomas,” Journal of Nuclear Medicine, vol. 47, no. 10, pp. 1612–1621, 2006. View at Google Scholar · View at Scopus
  7. W. Wang, J.-C. Georgi, S. A. Nehmeh et al., “Evaluation of a compartmental model for estimating tumor hypoxia via FMISO dynamic PET imaging,” Physics in Medicine and Biology, vol. 54, no. 10, pp. 3083–3099, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Radjenovic, B. J. Dall, J. P. Ridgway, and M. A. Smith, “Measurement of pharmacokinetic parameters in histologically graded invasive breast tumours using dynamic contrast-enhanced MRI,” British Journal of Radiology, vol. 81, no. 962, pp. 120–128, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. R. G. P. Lopata, W. H. Backes, P. P. J. van den Bosch, and N. A. W. van Riel, “On the identifiability of pharmacokinetic parameters in dynamic contrast-enhanced imagine,” Magnetic Resonance in Medicine, vol. 58, no. 2, pp. 425–429, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Brix, F. Kiessling, R. Lucht et al., “Microcirculation and microvasculature in breast tumors: pharmacokinetic analysis of dynamic MR image series,” Magnetic Resonance in Medicine, vol. 52, no. 2, pp. 420–429, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Martí-Bonmatí, R. Sopena, P. Bartumeus, and P. Sopena, “Multimodality imaging techniques,” Contrast Media and Molecular Imaging, vol. 5, no. 4, pp. 180–189, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. B. H. Hasagewa, E. L. Gingold, S. M. Reilly, S. C. Liew, and C. E. Cacc, “Description of a simultaneous emission-transmission CT system,” in Medical Imaging IV: Image Formation, vol. 1231 of Proceedings of SPIE, pp. 50–60, July 1990. View at Publisher · View at Google Scholar
  13. S. del Vecchio, A. Zannetti, R. Fonti et al., “PET/CT in cancer research: from preclinical to clinical applications,” Contrast Media and Molecular Imaging, vol. 5, no. 4, pp. 190–200, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Mariani, L. Bruselli, T. Kuwert et al., “A review on the clinical uses of SPECT/CT,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 37, no. 10, pp. 1959–1985, 2010. View at Google Scholar · View at Scopus
  15. G. Antoch and A. Bockisch, “Combined PET/MRI: a new dimension in whole-body oncology imaging?” European Journal of Nuclear Medicine and Molecular Imaging, vol. 36, supplement 1, pp. S113–S120, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. B. J. Pichler, A. Kolb, T. Nägele, and H.-P. Schlemmer, “PET/MRI: paving the way for the next generation of clinical multimodality imaging applications,” Journal of Nuclear Medicine, vol. 51, no. 3, pp. 333–336, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. T. E. Yankeelov, T. E. Peterson, R. G. Abramson et al., “Simultaneous PET-MRI in oncology: a solution looking for a problem?” Magnetic Resonance Imaging, vol. 30, no. 9, pp. 1342–1356, 2012. View at Google Scholar
  18. S. L. Barnes, J. G. Whisenant, M. E. Loveless, G. D. Ayers, and T. E. Yankeelov, “Assessing the reproducibility of dynamic contrast enhanced magnetic resonance imaging in a murine model of breast cancer,” Magnetic Resonance in Medicine, vol. 69, no. 6, pp. 1721–1734, 2013. View at Publisher · View at Google Scholar
  19. E. Henderson, B. K. Rutt, and T.-Y. Lee, “Temporal sampling requirements for the tracer kinetics modeling of breast disease,” Magnetic Resonance Imaging, vol. 16, no. 9, pp. 1057–1073, 1998. View at Publisher · View at Google Scholar · View at Scopus
  20. J. U. Fluckiger, M. C. Schabel, and E. V. R. DiBella, “Toward local arterial input functions in dynamic contrast-enhanced MRI,” Journal of Magnetic Resonance Imaging, vol. 32, no. 4, pp. 924–934, 2010. View at Google Scholar · View at Scopus
  21. J. Li, Y. Yu, Y. Zhang et al., “A clinically feasible method to estimate pharmacokinetic parameters in breast cancer,” Medical Physics, vol. 36, no. 8, pp. 3786–3794, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. S. L. Barnes, J. G. Whisenant, M. E. Loveless, G. D. Ayers, and T. E. Yankeelov, “Assessing the reproducibility of dynamic contrast enhanced magnetic resonance imaging in a murine model of breast cancer,” Magnetic Resonance in Medicine, vol. 69, no. 6, pp. 1721–1734, 2013. View at Publisher · View at Google Scholar
  23. S. M. Galbraith, M. A. Lodge, N. J. Taylor et al., “Reproducibility of dynamic contrast-enhanced MRI in human muscle and tumours: comparison of quantitative and semi-quantitative analysis,” NMR in Biomedicine, vol. 15, no. 2, pp. 132–142, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. A. R. Padhani, C. Hayes, S. Landau, and M. O. Leach, “Reproducibility of quantitative dynamic MRI of normal human tissues,” NMR in Biomedicine, vol. 15, no. 2, pp. 143–153, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. A. J. de Langen, M. Lubberink, R. Boellaard et al., “Reproducibility of tumor perfusion measurements using 15O-labeled water and PET,” Journal of Nuclear Medicine, vol. 49, no. 11, pp. 1763–1768, 2008. View at Publisher · View at Google Scholar · View at Scopus